• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[1984年至1988年菲尼斯泰尔省食管癌表皮样癌的治疗与生存情况(716例)]

[Treatment of and survival after epidermoid cancer of the esophagus in the department of Finistère between 1984 and 1988 (716 cases)].

作者信息

Calament G, Cauvin J M, Robaskiewicz M, Nousbaum J B, Lepage M, Robert F X, Gourlaouen A, Gouérou H

机构信息

Service de Gastroentérologie, CHU Morvan, Brest.

出版信息

Gastroenterol Clin Biol. 1993;17(1):9-16.

PMID:8467980
Abstract

The incidence of esophageal cancer in the French county of Finistère is among the highest in France (26.7/10(5) for males). The authors analyzed the survival rates for squamous cell carcinomas from data of the Finistère tumor registry in order to describe different prognostic groups of patients using the multivariate Cox model. From 1984 to 1988, 716 patients with esophageal squamous cell carcinomas were registered in an overall population of 828,000 residents: 675 males and 41 females. Survival was calculated using the actuarial method. Six hundred and seventy five patients died before the point date (31 Dec 1989). Only one patient was lost to follow-up. The actuarial survival rates of all patients were 89 +/- 1% at 3 months, 68 +/- 2% at 6 months, 37 +/- 2% at one year, 12 +/- 1% at 3 years and 6 +/- 1% at 5 years; median survival was 9.1 +/- 0.4 months. Survival was significantly related to cancer size, tumor extension and surgical contraindications. In the Cox model, age, cancer size, surgical contraindications, year of diagnosis were independent prognostic predictors. There was a significant increase in survival rates after 1986: median survival was 8.1 +/- 0.4 months between 1984 and 1986 and 10.1 +/- 0.5 months between 1987 and 1988. Patients treated by curative resection had higher actuarial survival rates (median survival 22.5 +/- 4.1 months) than patients who underwent palliative resection (median survival 11.3 +/- 1.2 months). In patients with cancer managed surgically, the prognostic predictors were tumor size, curative vs palliative surgical resection and association with chemotherapy.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

法国菲尼斯泰尔省的食管癌发病率在法国位居前列(男性发病率为26.7/10⁵)。作者分析了菲尼斯泰尔肿瘤登记处的数据中鳞状细胞癌的生存率,以便使用多变量Cox模型描述不同的患者预后组。1984年至1988年期间,在82.8万居民的总人口中登记了716例食管鳞状细胞癌患者:675例男性和41例女性。采用精算方法计算生存率。675例患者在截止日期(1989年12月31日)前死亡。仅1例患者失访。所有患者的精算生存率在3个月时为89±1%,6个月时为68±2%,1年时为37±2%,3年时为12±1%,5年时为6±1%;中位生存期为9.1±0.4个月。生存率与肿瘤大小、肿瘤扩展和手术禁忌证显著相关。在Cox模型中,年龄、肿瘤大小、手术禁忌证、诊断年份是独立的预后预测因素。1986年后生存率显著提高:1984年至1986年期间中位生存期为8.1±0.4个月,1987年至1988年期间为10.1±0.5个月。接受根治性切除的患者精算生存率(中位生存期22.5±4.1个月)高于接受姑息性切除的患者(中位生存期11.3±1.2个月)。在接受手术治疗的癌症患者中,预后预测因素为肿瘤大小、根治性与姑息性手术切除以及是否联合化疗。(摘要截取自250字)

相似文献

1
[Treatment of and survival after epidermoid cancer of the esophagus in the department of Finistère between 1984 and 1988 (716 cases)].[1984年至1988年菲尼斯泰尔省食管癌表皮样癌的治疗与生存情况(716例)]
Gastroenterol Clin Biol. 1993;17(1):9-16.
2
Oncologic outcomes of salvage surgery for epidermoid carcinoma of the anus initially managed with combined modality therapy.最初采用综合治疗的肛门表皮样癌挽救性手术的肿瘤学结局。
Dis Colon Rectum. 2004 Jul;47(7):1136-44. doi: 10.1007/s10350-004-0548-5. Epub 2004 May 28.
3
[Therapeutic management and survival of gastric adenocarcinoma in the province of Finistère between 1984 and 1989].[1984年至1989年间菲尼斯泰尔省胃腺癌的治疗管理与生存情况]
Gastroenterol Clin Biol. 1995 Oct;19(10):804-10.
4
Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.诱导化疗改善了接受放化疗后手术的可切除食管癌患者的预后。
Int J Radiat Oncol Biol Phys. 2004 Oct 1;60(2):427-36. doi: 10.1016/j.ijrobp.2004.03.033.
5
Predictors of long-term survival after resection of esophageal carcinoma with nonregional nodal metastases.伴有非区域淋巴结转移的食管癌切除术后长期生存的预测因素。
Ann Thorac Surg. 2009 Jul;88(1):186-92; discussion 192-3. doi: 10.1016/j.athoracsur.2009.03.079.
6
[Cox regression analysis of the prognostic factors of unresectable esophageal carcinoma after stenting].[食管癌支架置入术后不可切除食管癌预后因素的Cox回归分析]
Ai Zheng. 2003 Jan;22(1):91-4.
7
Management for patients with advanced T4 epidermoid carcinoma of the esophagus.晚期食管T4期表皮样癌患者的管理。
J Surg Oncol. 1996 May;62(1):22-9. doi: 10.1002/(SICI)1096-9098(199605)62:1<22::AID-JSO5>3.0.CO;2-T.
8
Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.同步放化疗后行食管癌切除术可改善临床II期或III期食管癌患者的局部区域控制。
Int J Radiat Oncol Biol Phys. 2004 Dec 1;60(5):1484-93. doi: 10.1016/j.ijrobp.2004.05.056.
9
Survival of patients with carcinoma of the esophagus treated with combined-modality therapy.采用综合治疗的食管癌患者的生存率。
J Thorac Cardiovasc Surg. 1993 Apr;105(4):749-55; discussion 755-6.
10
Refining esophageal cancer staging after neoadjuvant therapy: importance of treatment response.新辅助治疗后食管癌分期的细化:治疗反应的重要性。
Ann Surg Oncol. 2008 Oct;15(10):2894-902. doi: 10.1245/s10434-008-0084-y. Epub 2008 Jul 29.

引用本文的文献

1
[Descriptive and analytical study of esophageal cancer in Togo].[多哥食管癌的描述性与分析性研究]
Pan Afr Med J. 2014 Nov 21;19:315. doi: 10.11604/pamj.2014.19.315.4557. eCollection 2014.
2
Neoadjuvant chemoradiotherapy could improve survival outcomes for esophageal carcinoma: a meta-analysis.新辅助放化疗可改善食管癌患者的生存结局:一项荟萃分析。
Dig Dis Sci. 2012 Dec;57(12):3226-33. doi: 10.1007/s10620-012-2263-8. Epub 2012 Jun 14.
3
p53 protein accumulation in oesophageal squamous cell carcinomas and precancerous lesions.
p53蛋白在食管鳞状细胞癌及癌前病变中的积聚。
J Clin Pathol. 1995 Jun;48(6):531-4. doi: 10.1136/jcp.48.6.531.